The American Society of Hematology Annual Meeting, 2014

Advertisement

---

Bigger Regulatory Challenges in Diagnostics Than in Therapeutics, Industry Expert Says

Mary K. Caffrey

January 20th 2015

ArticleEvidence-Based Oncology

---

Best of ASH Presentations: Platelets, Lenalidomide for MDS, and Sorafenib in AML

Surabhi Dangi-Garimella, PhD

January 20th 2015

ArticleEvidence-Based Oncology

---

Improved Cancer Care Through Innovation

Surabhi Dangi-Garimella, PhD

January 20th 2015

ArticleEvidence-Based Oncology

---

Payers Look to CER for Improved Healthcare Decisions

Surabhi Dangi-Garimella, PhD

January 20th 2015

ArticleEvidence-Based Oncology

---

Data Show High Response Rate to Ibrutinib Combination for Patients With Hard-to-Treat MCL

Mary K. Caffrey

January 20th 2015

ArticleEvidence-Based Oncology

---

Results Project Savings for Payers With Novel Oral Anticoagulants

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

---

SPIRIT 2: Dasatinib Superior to Imatinib in Newly Diagnosed CML

Surabhi Dangi-Garimella, PhD

January 19th 2015

ArticleEvidence-Based Oncology

---

CML Updates: Defining MMR and Results of the DASISION Trial

Surabhi Dangi-Garimella, PhD

January 19th 2015

ArticleEvidence-Based Oncology

---

Sessions Report Phase 2 Results of Pomalidomide Combinations

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

---

Promising Results for Elotuzumab Presented in Session on Multiple Myeloma

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

Advertisement

---

Early Treatment, Monoclonal Antibodies Discussed in Multiple Myeloma

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

---

ASH Presents Second Round of Tests, Treatments to Question Under Choosing Wisely Initiative

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

---

Care Plans to Reduce Healthcare Utilization in Sickle Cell Disease

Surabhi Dangi-Garimella, PhD

January 19th 2015

ArticleEvidence-Based Oncology

---

Poster Presentations Cover Therapeutic Options in CML

Surabhi Dangi-Garimella, PhD

January 19th 2015

ArticleEvidence-Based Oncology

---

Healthcare Costs in Need of Solutions: Experts at ASH Agree

Surabhi Dangi-Garimella, PhD

January 19th 2015

ArticleEvidence-Based Oncology

---

Session on Survivorship Outlines Surveillance Strategies in Non-Hodgkin Lymphoma

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

---

Ibrutinib Demonstrates Significant Responses for Patients With Hard-to-Treat CLL/SLL, Phase 2 Data Show

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology

---

Study Suggests Method of Reducing Blood Clots Without Risking Bleeding

Mary K. Caffrey

January 19th 2015

ArticleEvidence-Based Oncology